2758 Is there a survival benefit for patients who receive post-operative adjuvant chemotherapy following secondary cytoreductive surgery (SCRS) for recurrent epithelial ovarian cancer (EOC)?

2015 ◽  
Vol 51 ◽  
pp. S550
Author(s):  
D. Kolomainen ◽  
J. Butler ◽  
D. P.J. Barton ◽  
A. Taylor ◽  
K. Stanley ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Adjuvant Chemotherapy ◽  
Epithelial Ovarian Cancer ◽  
Cytoreductive Surgery ◽  
Survival Benefit ◽  
Secondary Cytoreductive Surgery

No survival benefit with adjuvant chemotherapy in nonserous stage IB grade 2 epithelial ovarian cancer

2016 ◽  
Vol 141 ◽  
pp. 53-54
Author(s):  
S. Grabosch ◽  
J. Berger ◽  
M. Huang ◽  
S.E. Taylor ◽  
J.F. Lin ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Adjuvant Chemotherapy ◽  
Epithelial Ovarian Cancer ◽  
Survival Benefit ◽  
Stage Ib

Secondary cytoreductive surgery for recurrent epithelial ovarian cancer

1989 ◽  
Vol 34 (3) ◽  
pp. 334-338 ◽  
Author(s):  
Mitchell Morris ◽  
David M. Gershenson ◽  
J.Taylor Wharton ◽  
Larry J. Copeland ◽  
Creighton L. Edwards ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Cytoreductive Surgery ◽  
Secondary Cytoreductive Surgery

Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Cancer

2002 ◽  
Vol 99 (6) ◽  
pp. 1008-1013 ◽  
Author(s):  
Eng-Hseon Tay ◽  
Peter T. Grant ◽  
Val Gebski ◽  
Neville F. Hacker
Keyword(s):  
Ovarian Cancer ◽  
Epithelial Ovarian Cancer ◽  
Cytoreductive Surgery ◽  
Secondary Cytoreductive Surgery
Sign in / Sign up

Export Citation Format

Share Document